Activities of coagulation factors after optimized HHP treatment (200/250 Mpa, 5 cycles of 1min, at near 0°C temperature), n = 3.

<p>Activities of coagulation factors after optimized HHP treatment (200/250 Mpa, 5 cycles of 1min, at near 0°C temperature), n = 3.</p

Inactivation of <i>E</i>.<i>coli</i> under two mpHHP modes (200/250 Mpa, 5 cycles of 1min) at low temperature (near 0°C) and room temperature, n = 3.

<p>Inactivation of <i>E</i>.<i>coli</i> under two mpHHP modes (200/250 Mpa, 5 cycles of 1min) at low temperature (near 0°C) and room temperature, n = 3.</p

Inactivation of <i>E</i>.<i>coli</i> under mpHHP (5 cycles of 1 min) and spHHP (1 cycle of 5 min) application modes with escalated pressure, n = 3.

<p>Inactivation of <i>E</i>.<i>coli</i> under mpHHP (5 cycles of 1 min) and spHHP (1 cycle of 5 min) application modes with escalated pressure, n = 3.</p

Kinetics of bacterium inactivation by optimized HHP treatment (200/250 Mpa, 5 cycles of 1min, at near 0°C temperature), n = 3.

<p>Kinetics of bacterium inactivation by optimized HHP treatment (200/250 Mpa, 5 cycles of 1min, at near 0°C temperature), n = 3.</p

Activities of factor V and VIII after mpHHP treatment (200/250 Mpa, 5 cycles of 1min) at near 0°C temperature, n = 3.

<p>Activities of factor V and VIII after mpHHP treatment (200/250 Mpa, 5 cycles of 1min) at near 0°C temperature, n = 3.</p

The content of plasma proteins after HHP treatment (200/250 Mpa, 5 cycles of 1min, at near 0°C temperature), n = 3, mean±SD.

<p>The content of plasma proteins after HHP treatment (200/250 Mpa, 5 cycles of 1min, at near 0°C temperature), n = 3, mean±SD.</p

Change of activities of coagulation factor V and VIII under mpHHP treatments (5 cycles of 1 min) with escalated pressure (≥ 300MPa), n = 3.

<p>Change of activities of coagulation factor V and VIII under mpHHP treatments (5 cycles of 1 min) with escalated pressure (≥ 300MPa), n = 3.</p

Additional file 3: of KIR diversity in three ethnic minority populations in China

Table S2. PC1 and PC2 of 22 populations

Additional file 1: of KIR diversity in three ethnic minority populations in China

Figure S1. Map of China showing the city of three study populations. DNA samples of the Kazakh and Uyghur ethnic minority populations were collected from the Xinjiang autonomous region (Urumqi) of Northwest China, the Tibetan ethnic minority populations were collected from the Tibet autonomous region (Lhasa) of Southwest China

Additional file 2: of KIR diversity in three ethnic minority populations in China

Table S1.  KIR diversity in three ethnic minority populations in China with other populations